Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases
- on behalf of the REsponses to COVid-19 vaccinE IsRaeli IBD group [RECOVERI]
- Division of Gastroenterology
- Rabin Medical Center Israel
- Tel Aviv University
- Technion-Israel Institute of Technology
- Shaare Zedek Medical Center
- Hebrew University of Jerusalem
- Clalit Health Services
- Ariel University
- Holon Institute of Technology
- Sheba Medical Center at Tel Hashomer
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations